SE427841B - Analogiforfarande for framstellning av tienamycinderivat - Google Patents

Analogiforfarande for framstellning av tienamycinderivat

Info

Publication number
SE427841B
SE427841B SE7612963A SE7612963A SE427841B SE 427841 B SE427841 B SE 427841B SE 7612963 A SE7612963 A SE 7612963A SE 7612963 A SE7612963 A SE 7612963A SE 427841 B SE427841 B SE 427841B
Authority
SE
Sweden
Prior art keywords
tienamycin
derivatives
preparation
analogy procedure
analogy
Prior art date
Application number
SE7612963A
Other languages
English (en)
Swedish (sv)
Other versions
SE7612963L (sv
Inventor
B G Christensen
W J Leanza
K J Wildonger
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7612963L publication Critical patent/SE7612963L/xx
Publication of SE427841B publication Critical patent/SE427841B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE7612963A 1975-11-21 1976-11-19 Analogiforfarande for framstellning av tienamycinderivat SE427841B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63429675A 1975-11-21 1975-11-21
US67626176A 1976-04-12 1976-04-12
US73365476A 1976-10-18 1976-10-18

Publications (2)

Publication Number Publication Date
SE7612963L SE7612963L (sv) 1977-05-22
SE427841B true SE427841B (sv) 1983-05-09

Family

ID=27417545

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7612963A SE427841B (sv) 1975-11-21 1976-11-19 Analogiforfarande for framstellning av tienamycinderivat

Country Status (27)

Country Link
AT (1) AT358168B (de)
AU (1) AU512383B2 (de)
BG (1) BG34037A3 (de)
CA (1) CA1083577A (de)
CH (2) CH632510A5 (de)
DD (1) DD127742A5 (de)
DE (1) DE2652679A1 (de)
DK (1) DK157401C (de)
EG (1) EG12261A (de)
ES (1) ES453501A1 (de)
FI (1) FI62306C (de)
FR (1) FR2332012A1 (de)
GB (1) GB1570990A (de)
GR (1) GR62072B (de)
HK (1) HK29683A (de)
HU (1) HU180865B (de)
IE (1) IE44433B1 (de)
IL (1) IL50911A (de)
KE (1) KE3286A (de)
NL (1) NL189297C (de)
NO (1) NO153298C (de)
NZ (1) NZ182630A (de)
PH (1) PH16714A (de)
PL (1) PL110937B1 (de)
PT (1) PT65865B (de)
SE (1) SE427841B (de)
SG (1) SG10983G (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
SE436569B (sv) * 1977-05-05 1985-01-07 Merck & Co Inc Analogiforfarande for framstellning av tienamycinderivat
US4232030A (en) * 1977-09-15 1980-11-04 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone
DK153486C (da) * 1978-07-03 1988-11-28 Merck & Co Inc Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat
EP0044170A1 (de) * 1980-07-11 1982-01-20 Beecham Group Plc Beta-Lactam-Antibiotika, ihre Herstellung und Verwendung
CA2089261A1 (en) * 1990-08-30 1992-03-01 John F.W. Keana Substituted amidines having high binding to the sigma receptor and the use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1004670A (en) * 1963-04-23 1965-09-15 Beecham Res Lab Penicillins
GB1348984A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Antibiotics and processes for their production
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics

Also Published As

Publication number Publication date
SG10983G (en) 1983-12-16
NZ182630A (en) 1979-07-11
KE3286A (en) 1983-06-17
NL7612939A (nl) 1977-05-24
AU1964776A (en) 1978-05-25
DK523576A (da) 1977-05-22
CH633800A5 (en) 1982-12-31
GR62072B (en) 1979-02-20
PT65865B (en) 1978-10-12
NL189297B (nl) 1992-10-01
GB1570990A (en) 1980-07-09
ES453501A1 (es) 1978-03-01
NL189297C (nl) 1993-03-01
AT358168B (de) 1980-08-25
FI763308A (de) 1977-05-22
IL50911A (en) 1981-01-30
PT65865A (en) 1976-12-01
BG34037A3 (en) 1983-06-15
FR2332012B1 (de) 1978-11-17
PL193809A1 (pl) 1978-01-16
DE2652679C2 (de) 1990-03-01
IL50911A0 (en) 1977-01-31
HU180865B (en) 1983-04-29
NO763958L (de) 1977-05-24
SE7612963L (sv) 1977-05-22
DK157401B (da) 1990-01-02
PH16714A (en) 1984-01-25
NO153298C (no) 1986-02-19
IE44433B1 (en) 1981-12-02
CH632510A5 (en) 1982-10-15
PL110937B1 (en) 1980-08-30
HK29683A (en) 1983-08-26
FI62306B (fi) 1982-08-31
FI62306C (fi) 1982-12-10
CA1083577A (en) 1980-08-12
NO153298B (no) 1985-11-11
EG12261A (en) 1978-12-31
IE44433L (en) 1977-05-21
ATA863476A (de) 1980-01-15
DD127742A5 (de) 1977-10-12
DE2652679A1 (de) 1977-06-02
FR2332012A1 (fr) 1977-06-17
DK157401C (da) 1990-05-21
AU512383B2 (en) 1980-10-09

Similar Documents

Publication Publication Date Title
SE433208B (sv) Forfarande for framstellning av fenoletrar
SE422941B (sv) Analogiforfarande for framstellning av tetracykliska pyrido-bensazepinforeningar
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
AR217629A1 (es) Procedimiento de preparacion de derivados de tienotetrahidropiridina
SE427839B (sv) Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE419083B (sv) Analogiforfarande for framstellning av nikotinoylamino-triazinderivat
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE423814B (sv) Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat
SE427840B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE7606815L (sv) Forfarande for framstellning av nya naftacenderivat
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE423233B (sv) Analogiforfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE427558B (sv) Analogiforfarande for framstellning av 7-metoxicefalosporinderivat
SE7605427L (sv) Forfarande for framstellning av klorcyan
SE7603682L (sv) Forfarande for framstellning av en eteriskt substituerad monosackarid
SE7601247L (sv) Forfarande for framstellning av tienopyridinderivat
SE7604861L (sv) Forfarande for framstellning av bensobicyklononenderivat
SE434396B (sv) Analogiforfarande for framstellning av 4-amino-transdekahydrokinolinderivat

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7612963-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7612963-4

Format of ref document f/p: F